FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Boehringer Ingelheim Roxane Pradaxa Recall

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed…

Boehringer Ingelheim Roxane Inc · Columbus, OH

Risk level
Class II
Reported by FDA
Dec 5, 2012
Recall ID
D-067-2013
Check your lot numberHow we source this data

Summary

Boehringer Ingelheim Roxane recalled Pradaxa starting Nov 5, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-067-2013 on Dec 5, 2012. Reason: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product. Status: Terminated.

Why it was recalled

Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Product description

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

Lot numbers, UPCs & expiration codes

Lot 201900 Expiration Date: JAN 2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-067-2013
Classification
Class II
Status
Terminated
Recall initiated
Nov 5, 2012
FDA report date
Dec 5, 2012
Quantity
8,381 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Boehringer Ingelheim Roxane Inc

Original FDA data

Every field from FDA enforcement report D-067-2013, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
63630
Address
1809 Wilson Rd
Code information
Lot 201900 Expiration Date: JAN 2015
Postal code
43228-9579
Report date
Dec 5, 2012
Product type
Drugs
Recall number
D-067-2013
Classification
Class II
Recalling firm
Boehringer Ingelheim Roxane Inc
Product quantity
8,381 bottles
Termination date
Sep 18, 2013
Reason for recall
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54
Distribution pattern
Nationwide
Recall initiation date
Nov 5, 2012
Initial firm notification
Letter
Center classification date
Nov 26, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-067-2013, published Dec 5, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls